The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10439 malaria professionals are enjoying the free benefits of MalariaWorld today

southeast Sudan

Assessment of Plasmodium falciparum drug resistance molecular markers from the Blue Nile State, Southeast Sudan

February 24, 2020 - 13:56 -- Open Access
Author(s): 
Abdelrahim O. Mohamed, Maazza Hussien, Amal Mohamed, Abdelmaroof Suliman, Nuha S. Elkando, Hanadi Abdelbagi, Elfatih M. Malik, Mohammed H. Abdelraheem and Muzamil Mahdi Abdel Hamid
Reference: 
Malaria Journal 2020 19:78, 18 February 2020

Plasmodium falciparum malaria is a public health problem worldwide. Malaria treatment policy has faced periodic changes due to emergence of drug resistant parasites. In Sudan chloroquine has been replaced by artesunate and sulfadoxine/pyrimethamine (AS/SP) in 2005 and to artemether–lumefantrine (AL) in 2017, due to the development of drug resistance. Different molecular markers have been used to monitor the status of drug resistant P. falciparum. This study aimed to determine the frequency of malaria drug resistance molecular markers in Southeast Sudan.

Subscribe to RSS - southeast Sudan